Seventh Sense Biosystems is a privately held medical technology company focused on developing innovative blood collection devices used in research and clinical testing. Our mission is to eliminate the barriers to successful blood sample collection and testing for health care professionals and consumers with simple, safe, mobile, and nearly painless technologies. Through our innovative products, we hope to empower and engage consumers to take better care of their own health while improving the efficacy and quality of blood collection — one of the most common medical procedures performed. TAP Touch-Activated Phlebotomy™ is a proprietary platform that can be used to draw capillary blood in a one-step process without requiring venous access. TAP also simplifies and standardizes blood collection, and may help minimize variables that can impact sample and test quality.
Looking for a particular Seventh Sense Biosystems employee's phone or email?
The Seventh Sense Biosystems annual revenue was $6 million in 2026.
Paul Owen is the President and CEO of Seventh Sense Biosystems.
19 people are employed at Seventh Sense Biosystems.
Seventh Sense Biosystems is based in Medford, Massachusetts.
The NAICS codes for Seventh Sense Biosystems are [541714, 5417, 541, 54, 54171].
The SIC codes for Seventh Sense Biosystems are [87, 873].